# Bupropion and Restless Legs Syndrome

> **NCT00621517** · PHASE2,PHASE3 · COMPLETED · sponsor: **East Tennessee State University** · enrollment: 60 (actual)

## Conditions studied

- Restless Legs Syndrome

## Interventions

- **DRUG:** Bupropion
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00621517
- **Lead sponsor:** East Tennessee State University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2019-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00621517

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00621517, "Bupropion and Restless Legs Syndrome". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00621517. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*